-
1
-
-
37049183697
-
Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
-
Salmon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-182.
-
(1987)
Science
, vol.235
, pp. 177-182
-
-
Salmon, D.J.1
Clark, G.M.2
Wong, S.G.3
-
2
-
-
0031954313
-
Neu/ErB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
-
Toronto Breast Cancer Study Group
-
Andrulis IL, Bull SB, Blackstein ME, et al. Neu/ErB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol. 1998;16:1340-1349.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1340-1349
-
-
Andrulis, I.L.1
Bull, S.B.2
Blackstein, M.E.3
-
3
-
-
10344230552
-
Prognostic significance of HER-2/neu positive breast carcinoma as a particular subset with peculiar clinical behavior
-
Tetu B, Brisson J. Prognostic significance of HER-2/neu positive breast carcinoma as a particular subset with peculiar clinical behavior. Clin Cancer Res. 2002;8:520-525.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 520-525
-
-
Tetu, B.1
Brisson, J.2
-
4
-
-
0029662337
-
c-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early stage breast cancer without axillary lymph node metastases
-
Carlomagno C, Perrone F, Gallo C, et al. c-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early stage breast cancer without axillary lymph node metastases. J Clin Oncol. 1996;14:2702-2708.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2702-2708
-
-
Carlomagno, C.1
Perrone, F.2
Gallo, C.3
-
5
-
-
0034896257
-
Chemotherapy response of breast cancer depends on Her-2 status and anthracycline dose intensity in the neoadjuvant setting
-
Petit T, Borel C, Ghnassia JP, et al. Chemotherapy response of breast cancer depends on Her-2 status and anthracycline dose intensity in the neoadjuvant setting. Clin Cancer Res. 2001;7:1577-1581.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1577-1581
-
-
Petit, T.1
Borel, C.2
Ghnassia, J.P.3
-
6
-
-
0034780374
-
Significance of, and optimal screening for, Her-2 gene amplification and protein overexpression in breast carcinoma
-
Funkhouser WK, Kaiser-Rogers K. Significance of, and optimal screening for, Her-2 gene amplification and protein overexpression in breast carcinoma [Review]. Ann Clin Lab Sci. 2001;31:349-357.
-
(2001)
Ann Clin Lab Sci
, vol.31
, pp. 349-357
-
-
Funkhouser, W.K.1
Kaiser-Rogers, K.2
-
7
-
-
0032875086
-
Evaluation of the HER-2/neu (erbB-2) status in breast cancer: From bench to bedside
-
Hanna W, Kahn HGJ, Trudeau M. Evaluation of the HER-2/neu (erbB-2) status in breast cancer: from bench to bedside. Med Pathol. 1999;12:827-834.
-
(1999)
Med Pathol
, vol.12
, pp. 827-834
-
-
Hanna, W.1
Kahn, H.G.J.2
Trudeau, M.3
-
8
-
-
0031010751
-
Prognosis among African-American women and white women with lymph node negative breast carcinoma. Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
-
Dignam JJ, Redmond CK, Fisher B, et al. Prognosis among African-American women and white women with lymph node negative breast carcinoma. Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer. 1997;80:80-90.
-
(1997)
Cancer
, vol.80
, pp. 80-90
-
-
Dignam, J.J.1
Redmond, C.K.2
Fisher, B.3
-
9
-
-
0033984903
-
Differences in breast cancer prognosis among African-American and Caucasian women
-
Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA-Cancer J Clin. 2000;50:50-64.
-
(2000)
CA-Cancer J Clin
, vol.50
, pp. 50-64
-
-
Dignam, J.J.1
-
10
-
-
0037215974
-
Overview of the summit meeting evaluating research in African-American women
-
Jones LA, Brawley O, Johnson-Thompson M, et al. Overview of the summit meeting evaluating research in African-American women. Cancer. 2003;97:207-210.
-
(2003)
Cancer
, vol.97
, pp. 207-210
-
-
Jones, L.A.1
Brawley, O.2
Johnson-Thompson, M.3
-
11
-
-
0036604262
-
African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast
-
Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002;94:2844-2854.
-
(2002)
Cancer
, vol.94
, pp. 2844-2854
-
-
Newman, L.A.1
Mason, J.2
Cote, D.3
-
12
-
-
0033983963
-
Racial differences in breast carcinoma survival
-
Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114-123.
-
(2000)
Cancer
, vol.88
, pp. 114-123
-
-
Joslyn, S.A.1
West, M.M.2
-
13
-
-
0035985483
-
Hormone receptors in breast cancer: Racial differences in distribution and survival
-
Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73:45-59.
-
(2002)
Breast Cancer Res Treat
, vol.73
, pp. 45-59
-
-
Joslyn, S.A.1
-
14
-
-
0029866754
-
Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic women. An analysis of 13,239 cases
-
Gapstur SM, Dupuis J, Gann P, et al. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic women. An analysis of 13,239 cases. Cancer. 1996;77: 1465-1471.
-
(1996)
Cancer
, vol.77
, pp. 1465-1471
-
-
Gapstur, S.M.1
Dupuis, J.2
Gann, P.3
-
15
-
-
0023100401
-
A comparison of estrogen and progesterone receptors in black and white breast cancer patients
-
Beverly LN, Flanders WD, GO RCP, et al. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health. 1987;77:351-353.
-
(1987)
Am J Public Health
, vol.77
, pp. 351-353
-
-
Beverly, L.N.1
Flanders, W.D.2
Go, R.C.P.3
-
16
-
-
0037108283
-
Racial differences in treatment and survival from early stage breast carcinoma
-
Joslyn SA. Racial differences in treatment and survival from early stage breast carcinoma. Cancer. 2002;95:1759-1766.
-
(2002)
Cancer
, vol.95
, pp. 1759-1766
-
-
Joslyn, S.A.1
-
17
-
-
0023841565
-
The prognostic value and relationships of patient characteristics, estrogen and progesterone receptors, and site of relapse in primary breast cancer
-
Alexieva-Figusch J, Van Putten WI, Blankenstein MA, et al. The prognostic value and relationships of patient characteristics, estrogen and progesterone receptors, and site of relapse in primary breast cancer. Cancer. 1988;61:758-768.
-
(1988)
Cancer
, vol.61
, pp. 758-768
-
-
Alexieva-Figusch, J.1
Van Putten, W.I.2
Blankenstein, M.A.3
-
18
-
-
0036645259
-
Ethnicity related differences in the survival of young breast carcinoma patients
-
Newman LA, Bunner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer. 2002;95:21-27.
-
(2002)
Cancer
, vol.95
, pp. 21-27
-
-
Newman, L.A.1
Bunner, S.2
Carolin, K.3
-
19
-
-
0029039188
-
Ethnic differences in risk and prognostic factors for breast cancer
-
Weiss SE, Tamer PI, Ahmed S, et al. Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 1995; 76:268-274.
-
(1995)
Cancer
, vol.76
, pp. 268-274
-
-
Weiss, S.E.1
Tamer, P.I.2
Ahmed, S.3
-
20
-
-
0028217282
-
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States
-
Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 705-712
-
-
Elledge, R.M.1
Clark, G.M.2
Chamness, G.C.3
-
22
-
-
0033142114
-
Prognostic value of plasma HER-2/new in African-American and Hispanic women with breast cancer
-
Wu Y, Khan H, Chillar R, et al. Prognostic value of plasma HER-2/new in African-American and Hispanic women with breast cancer. Int J Oncol. 1999;14:1021-1037.
-
(1999)
Int J Oncol
, vol.14
, pp. 1021-1037
-
-
Wu, Y.1
Khan, H.2
Chillar, R.3
-
23
-
-
0037440261
-
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
-
Konecny G, Pauletti G, Pegram M, et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst. 2003;95:142-153.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 142-153
-
-
Konecny, G.1
Pauletti, G.2
Pegram, M.3
-
24
-
-
0345098483
-
Do we need HER-2/neu testing for all patients with primary breast carcinoma?
-
Taucher S, Rudas M, Mader RM, et al. Do we need HER-2/ neu testing for all patients with primary breast carcinoma? Cancer. 2003;98:2547-2453.
-
(2003)
Cancer
, vol.98
, pp. 2547-12453
-
-
Taucher, S.1
Rudas, M.2
Mader, R.M.3
-
25
-
-
0032055144
-
Breast carcinoma survival analysis for African-American and white women in an equal-access healthcare system
-
Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African-American and white women in an equal-access healthcare system. Cancer. 1998;82:1310-1318.
-
(1998)
Cancer
, vol.82
, pp. 1310-1318
-
-
Wojcik, B.E.1
Spinks, M.K.2
Optenberg, S.A.3
-
26
-
-
0041887167
-
Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense healthcare system
-
Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense healthcare system. Cancer. 2003;98:894-899.
-
(2003)
Cancer
, vol.98
, pp. 894-899
-
-
Jatoi, I.1
Becher, H.2
Leake, C.R.3
-
27
-
-
0041736242
-
Racial/ethnic disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy
-
Griggs JJ, Sorbero ME, Stark A, et al. Racial/ethnic disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81:21-31.
-
(2003)
Breast Cancer Res Treat
, vol.81
, pp. 21-31
-
-
Griggs, J.J.1
Sorbero, M.E.2
Stark, A.3
-
28
-
-
2642575788
-
Racial differences in the expression of cell cycle regulator proteins in breast carcinoma. Study of young African-American and white women in Atlanta, Georgia
-
Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle regulator proteins in breast carcinoma. Study of young African-American and white women in Atlanta, Georgia. Cancer. 2004;100:2533-2542.
-
(2004)
Cancer
, vol.100
, pp. 2533-2542
-
-
Porter, P.L.1
Lund, M.J.2
Lin, M.G.3
-
29
-
-
4444286069
-
African American/white differences in breast carcinoma. P53 alterations and other tumor characteristics
-
Jones BA, Kasi SV, Howe CL, et al. African American/white differences in breast carcinoma. P53 alterations and other tumor characteristics. Cancer. 2004;101:1293-1301.
-
(2004)
Cancer
, vol.101
, pp. 1293-1301
-
-
Jones, B.A.1
Kasi, S.V.2
Howe, C.L.3
-
30
-
-
0036468764
-
Functionally active estrogen receptor isoform profiles in the breast tumors of African-American women are different from the profiles in breast tumors of Caucasian women
-
Poola I, Clarke R, DeWitty R, et al. Functionally active estrogen receptor isoform profiles in the breast tumors of African-American women are different from the profiles in breast tumors of Caucasian women. Cancer. 2002;94:615-623.
-
(2002)
Cancer
, vol.94
, pp. 615-623
-
-
Poola, I.1
Clarke, R.2
DeWitty, R.3
-
31
-
-
0037012341
-
Disaggregating the effects of race and poverty on breast cancer outcomes
-
Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 471-473
-
-
Brawley, O.W.1
-
32
-
-
0028842829
-
Association of education and income with estrogen receptor status in primary breast cancer
-
Gordon NH. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemol. 1995;142:796-803.
-
(1995)
Am J Epidemol
, vol.142
, pp. 796-803
-
-
Gordon, N.H.1
-
33
-
-
2642573558
-
Participation in cancer clinical trials. Race-, sex- and age-based disparities
-
Murthy VH, Krumholz HM, Gross GP. Participation in cancer clinical trials. Race-, sex- and age-based disparities. JAMA. 2004;291:2720-2726.
-
(2004)
JAMA
, vol.291
, pp. 2720-2726
-
-
Murthy, V.H.1
Krumholz, H.M.2
Gross, G.P.3
-
34
-
-
27644572328
-
-
National Institutes of Health. http://www4.od.nih.gov/ orwh/revitalization.pdf [accessed Nov 15, 2004].
-
-
-
|